Skip to main content

Media centre

Solventum to Report Second Quarter 2024 Financial Results and Host Conference Call on August 8, 2024

Press release | Company news
July 16, 2024

Solventum (NYSE: SOLV) will release its second quarter 2024 financial results on Thursday, August 8, 2024 after the U.S. financial markets close. The company will also host a conference call that...

Read more

Featured news
Solventum Cautions Investors Regarding TRC Capital's "Mini-Tender Offer"

Solventum (NYSE: SOLV) has been notified that TRC Capital Investment Corporation ("TRC") made an unsolicited "mini-tender offer" to purchase up to 2,000,000 shares of the company's common stock at...

Learn more

Solventum Reports First Quarter 2024 Financial Results and Capital Allocation Update

Completed spin-off from 3M and began trading on April 1, 2024 Reported sales increased 0.2% to $2.016 billion, organic sales increased 0.9% GAAP Earnings Per Share (EPS) of $1.37; adjusted EPS1 of...

Learn more

Press releases
Press release
Nov 19, 2024

Solventum (NYSE: SOLV) announced today that its executives will participate in a fireside chat at the Piper Sandler 36th Annual Healthcare Conference on Wednesday, December 4, 2024 at 11:30 a.m. ET in

Read more

Press release
Nov 14, 2024

Clarity Precision Grip Attachments are fully cured, pre-loaded and precisely resemble the digital treatment plan after bonding ST. PAUL, Minn., Nov. 14, 2024 /PRNewswire/ -- This month, Solventum...

Read more

Press release
Nov 7, 2024

Reported sales increased 0.4% to $2.082 billion; organic sales increased 0.3% GAAP Earnings Per Share (EPS) of $0.70; adjusted EPS1 of $1.64 Generated $169 million in cash from operations; free...

Read more

See all news

In the news
Resources
Brand images
Solventum logos
Fact sheet
Contact Media Relations

These contacts are intended only for the media. If you are not a member of the media, please call 1-855-423-6725 (1-855-HC FOR ALL).

Contact us